TCL Archive ACS President & COO Resigns Unexpectedly; Was Seen as Contender for CEO Position December 19, 2014
TCL Archive EPO Controversy: ODAC To Review EPO Agents in May; SEC Probes Amgen’s Delay in Study Disclosure. March 2, 2007
TCL Archive In Brief: NCAB Approves Concept Of Converting Baltimore Program To Cancer Center; New DCCP Labs Named June 5, 1981
TCL Archive Capitol Hill: Senate bill would allow sale of therapies for catastrophic illness after phase I trials. December 2, 2005
